angiotensin ii has been researched along with Hyperglycemia in 94 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (8.51) | 18.7374 |
1990's | 15 (15.96) | 18.2507 |
2000's | 37 (39.36) | 29.6817 |
2010's | 32 (34.04) | 24.3611 |
2020's | 2 (2.13) | 2.80 |
Authors | Studies |
---|---|
Bai, HY; Gu, HB; Li, H; Shan, BS; Zhou, X | 1 |
Capozzi, ME; Padovani-Claudio, DA; Penn, JS; Ramos, CJ | 1 |
Advani, A; Cherney, DZI; Fong, D; Har, R; Lai, V; Locke, A; Lytvyn, Y; Perkins, BA | 1 |
de Queiroz, DB; Duarte, GP; Ramos-Alves, FE; Santos-Rocha, J; Xavier, FE | 1 |
Fang, WJ; Shyu, KG; Wang, BW | 1 |
Abu Hamad, R; Berman, S; Efrati, S | 1 |
Chhabra, KH; Lazartigues, E; Pedersen, KB; Speth, RC; Xia, H | 1 |
Liu, ML; Qiu, Q; Wang, L; Wu, XL; Xu, YZ; Zhang, F; Zhang, GR; Zhang, X | 1 |
Auger, C; Kang, M; Kim, KR; Lee, JO; Oak, MH; Park, DH; Schini-Kerth, VB | 1 |
Abdul, A; Deb, DK; Heilig, CW; James, LR; Nahman, NS; Riaz, H; Salameh, J | 1 |
Cherney, DZ; Maahs, DM; Perkins, BA; Yang, GK | 1 |
Bigagli, E; Lodovici, M; Manni, ME; Musilli, C; Raimondi, L; Zazzeri, M | 1 |
Cai, L; Fang, Q; Huang, Y; Liang, G; Miao, L; Pan, Y; Peng, K; Sun, Y; Tong, C; Wang, Y; Wang, Z; Zhao, Y | 1 |
Kotov, AV; Pevtsova, EI; Shoibonov, BB; Tolpygo, SM | 1 |
De Mello, WC | 1 |
Bagal, S; Gaikwad, AB; Goru, SK; Kadakol, A; Malek, V; Pandey, A | 1 |
Harris, NR; Lee, S | 1 |
Kawasaki, H; Kitamura, Y; Mio, M; Miyashita, S; Takatori, S; Yamawaki, K; Zamami, Y | 1 |
Averbukh, Z; Berman, S; Efrati, S; Tov, YS; Weissgarten, J | 1 |
Fukumoto, M; Hayashi, T; Ikeda, T; Jin, D; Kitaura, Y; Miyazaki, M; Oku, H; Sugiyama, T; Takai, S | 1 |
Aoyama, I; Bomsztyk, K; Komers, R; Koopmeiners, JS; Naito, M; Schnaper, HW; Shenoy, A | 1 |
De Geest, B; Egorova, M; Jacobs, F; Lorenz, M; Meloni, M; Schultheiss, HP; Spillmann, F; Stangl, V; Tschöpe, C; Van Linthout, S | 1 |
Hua, P; Jaimes, EA; Raij, L; Tian, RX | 1 |
Han, HJ; Kim, YH; Lee, YJ; Ryu, JM | 1 |
Bradley, TJ; Cherney, DZ; Dekker, MG; Lai, V; Miller, JA; Reich, HN; Scholey, JW; Sochett, EB; Zinman, B | 1 |
Huang, Y; Lu, LM; Ni, J; Xue, H; Yu, C; Yuan, P; Zhou, L | 1 |
Barnes, JL; Cavaglieri, Rde C; Day, RT; Feliers, D; Kasinath, BS; Lee, MJ; Mantravadi, V; Tabatabaimir, H | 1 |
Abdulla, MH; Abdullah, NA; Anand Swarup, KR; Hye Khan, MA; Johns, EJ; Sattar, MA | 1 |
Baker, KM; Choudhary, R; Guleria, RS; Pan, J; Tanaka, T | 1 |
Abdulla, MH; Abdullah, NA; Hye Khan, MA; Johns, EJ; Rathore, HA; Sattar, MA | 1 |
Lee, KO; Sim, MK; Wong, YC | 1 |
Akhtar, S; Al-Farsi, O; Benter, IF; Chandrasekhar, B; Dhaunsi, GS; Yousif, MH | 1 |
Berman, S; Chanimov, M; Efrati, S; Hamad, RA; Siman-Tov, Y; Weissgarten, J | 1 |
Leung, KK; Leung, PS; Liang, J; Ma, MT | 1 |
Baker, KM; Kumar, R; Thomas, CM; Yong, QC | 1 |
Bradley, TJ; Cherney, DZ; Lai, V; Reich, HN; Scholey, JW; Slorach, C; Zinman, B | 1 |
Chihara, Y; Denda, A; Fujii, K; Kuniyasu, H; Luo, Y; Ohmori, H; Sasahira, T; Shimomoto, T; Tatsumoto, N | 1 |
Akhtar, S; Benter, IF; Dhaunsi, GS; Makki, BM; Qabazard, BA; Yousif, MH | 1 |
Müller-Fielitz, H; Raasch, W | 1 |
Kotov, AV; Loseva, TN; Pevtsova, EI; Tolpygo, SM | 1 |
Kanwar, YS; Sahai, A; Sodhi, CP | 1 |
Mohanram, A; Toto, RD | 1 |
Bolick, DT; Hatley, ME; Hedrick, CC; Nadler, JL; Srinivasan, S | 1 |
Funatsu, H; Yamashita, H | 1 |
Amiri, F; Banes, AK; Jenkins, J; Marrero, MB; Pollock, DM; Redd, H; Shaw, S | 1 |
Arun, KH; Kaul, CL; Poduri, R | 1 |
De Vriese, AS; Flyvbjerg, A; Schrijvers, BF | 1 |
Mozaffari, M; Pastukh, V; Ricci, C; Schaffer, S; Wu, S | 1 |
Wang, YX | 1 |
Chen, KY; Chuang, M; Hunt, D; Kargacin, G; Severson, DL; Shimoni, Y | 1 |
Kadowaki, T; Yamamoto-Honda, R | 1 |
Nagaria, AM; Reddy, S; Savin, VJ; Sharma, M; Sharma, R; Wiegmann, TB | 1 |
Cooper, ME; Thomas, MC; Tikellis, C | 1 |
Cai, H; Oak, JH | 1 |
Arafat, HA; Chipitsyna, G; Gong, Q; Gray, CF; Haroon, Y; Kamer, E | 1 |
Gaikwad, AB; Ramarao, P; Viswanad, B | 1 |
Han, HJ; Lee, YJ | 1 |
Casarini, DE; Fiorino, P; Irigoyen, MC; Lagranha, CJ; Schaan, BD | 1 |
Gao, L; Kern, TS; Xi, X; Zhang, JZ | 1 |
Camussi, G; Gruden, G; Perin, PC | 1 |
Fulton, D; Marrero, MB; Stepp, D; Stern, DM | 1 |
Jong, CJ; Ricci, C; Schaffer, SW | 1 |
Leung, KK; Leung, PS | 1 |
Blantz, RC; Pelayo, JC | 1 |
Coimbra, CC; Machado, LJ; Marubayashi, U; Mihessen-Neto, I; Reis, AM | 1 |
Griffin, CA; Schambelan, M; Sechi, LA | 1 |
Elton, TS; Guest, LL; Marchase, RB; Rivera, AA; White, CR | 1 |
Coimbra, CC; Machado, LJ; Marubayashi, U; Reis, AM | 2 |
Bai, W; Gonzales, N; Lanting, L; Nadler, J; Natarajan, R | 1 |
Faraday, N; Nguyen, ND; Rosenfeld, BA; Sung, I | 1 |
McCarty, MF | 1 |
Grupp, LA; Harding, S; Lau, V | 1 |
Dusting, GJ; Ritchie, RH; Rosenkranz, AC | 1 |
Miller, JA | 1 |
Coimbra, CC; Foscolo, DR; Garofalo, MA; Migliorini, RH; Xavier, AR | 1 |
Amiri, F; Ju, H; Marrero, MB; Venema, RC; Venema, VJ; Wang, X | 1 |
Hollenberg, NK; Laffel, LM; Lansang, MC; Osei, SY; Price, DA | 1 |
Andersson, A; Carlsson, PO; Jansson, L; Olsson, R | 1 |
Broadbent, DM | 1 |
Brownlee, M; Draznin, B; Goalstone, ML; Golovchenko, I; Watson, P | 1 |
Anversa, P; Cesselli, D; Fiordaliso, F; Kajstura, J; Leri, A; Limana, F; Nadal-Ginard, B; Safai, B | 1 |
Srivastava, AK | 1 |
Du, J; Fujisawa, G; Fujita, N; Furukawa, Y; Ishibashi, S; Itabashi, N; Okada, K; Saito, T | 1 |
Brodbeck, K; Häring, HU; Klopfer, K; Schleicher, ED; Weigert, C | 1 |
Assal, JP; Christlieb, AR; Katsilambros, N; Kozak, GP; Suzuki, T; Williams, GH | 1 |
Hetey, L; Konitzer, K; Voigt, S | 1 |
Simmons, DA; Winegrad, AI | 1 |
Andreis, PG; Cavallini, L; Mazzocchi, G; Nussdorfer, GG; Rebuffat, P | 1 |
Brown, MR; Fisher, LA | 1 |
Clements, RS; Morrison, AD; Winegrad, AI | 1 |
Masumura, S; Ono, K | 1 |
Hori, S; Masumura, S; Ono, K | 1 |
Hori, S; Masumura, S; Ono, K; Sato, Y | 1 |
18 review(s) available for angiotensin ii and Hyperglycemia
Article | Year |
---|---|
Elucidating glial responses to products of diabetes-associated systemic dyshomeostasis.
Topics: Angiotensin II; Diabetes Mellitus; Diabetic Retinopathy; Glucose; Humans; Hyperglycemia; Hypertension; Neuroglia; Palmitic Acid | 2023 |
GLUT1 regulation of the pro-sclerotic mediators of diabetic nephropathy.
Topics: Angiotensin II; Animals; Connective Tissue Growth Factor; Diabetic Nephropathies; Glucose; Glucose Transporter Type 1; Humans; Hyperglycemia; Signal Transduction; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2013 |
Intracellular angiotensin II disrupts chemical communication and impairs metabolic cooperation between cardiac myocytes.
Topics: Angiotensin II; Animals; Cell Communication; Heart Failure; Humans; Hyperglycemia; Myocardial Ischemia; Myocytes, Cardiac; Renin-Angiotensin System | 2015 |
Intracardiac intracellular angiotensin system in diabetes.
Topics: Angiotensin II; Animals; Cricetinae; Diabetes Mellitus; Diabetic Cardiomyopathies; Disease Models, Animal; Heart; Hyperglycemia; Mice; Myocardium; Rats; Renin-Angiotensin System | 2012 |
Outcome studies in diabetic nephropathy.
Topics: Albuminuria; Anemia; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hyperglycemia; Hyperlipidemias; Hypertension, Renal; Irbesartan; Kidney Failure, Chronic; Male; Outcome Assessment, Health Care; Proteinuria; Renin-Angiotensin System; Risk Factors; Smoking; Tetrazoles | 2003 |
Pathogenesis of diabetic retinopathy and the renin-angiotensin system.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Diabetic Retinopathy; Disease Progression; Humans; Hyperglycemia; Hypertension; Macular Degeneration; Receptors, Angiotensin; Renin-Angiotensin System; Risk Factors; Vascular Endothelial Growth Factors | 2003 |
From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines.
Topics: Aldehyde Reductase; Angiotensin II; Animals; Cytokines; Diabetic Nephropathies; Diglycerides; Endothelins; Glycation End Products, Advanced; Growth Substances; Hemodynamics; Humans; Hyperglycemia; Nitric Oxide; Protein Kinases | 2004 |
Cardiovascular functional phenotypes and pharmacological responses in apolipoprotein E deficient mice.
Topics: Angiotensin II; Animals; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Cardiac Output, High; Cardiomegaly; Cardiovascular System; Enzyme Inhibitors; Estradiol; Hypercholesterolemia; Hyperglycemia; Mice; Mice, Knockout; NG-Nitroarginine Methyl Ester; Phenotype; Simvastatin | 2005 |
[Protein kinase C activation and diabetic complications].
Topics: Angiotensin II; Animals; Diabetes Complications; Diglycerides; Enzyme Activation; Glycation End Products, Advanced; Humans; Hyperglycemia; Isoenzymes; Polymers; Protein Kinase C; Reactive Oxygen Species | 2005 |
Chronically increased intrarenal angiotensin II causes nephropathy in an animal model of type 2 diabetes.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Blood Pressure; Chromatography; Collagen; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Fibronectins; Glucose; Hyperglycemia; Immunoblotting; Insulin; Insulin Resistance; Kidney; Male; Models, Statistical; Obesity; Proteinuria; Radioimmunoassay; Rats; Rats, Zucker; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1; Up-Regulation | 2006 |
Role of the renin-angiotensin system in the endocrine pancreas: implications for the development of diabetes.
Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fibrosis; Humans; Hyperglycemia; Hypoglycemia; Islets of Langerhans; Pancreas; Peptidyl-Dipeptidase A; PPAR gamma; Receptors, Angiotensin; Renin; Renin-Angiotensin System | 2006 |
Regulatory mechanisms of Na(+)/glucose cotransporters in renal proximal tubule cells.
Topics: Angiotensin II; Animals; Diabetic Nephropathies; Dogs; Epidermal Growth Factor; ErbB Receptors; Glucose; Humans; Hyperglycemia; Kidney Tubules, Proximal; Mice; Rabbits; Rats; Sodium-Glucose Transport Proteins | 2007 |
[Molecular bases of diabetic nephropathy].
Topics: Angiotensin II; Cell Proliferation; Diabetic Nephropathies; Endothelium-Dependent Relaxing Factors; Extracellular Matrix; Glomerular Mesangium; Glucose Transporter Type 1; Glycation End Products, Advanced; Humans; Hyperglycemia; Nitric Oxide; Oxidative Stress; Renin-Angiotensin System; Sclerosis; Transforming Growth Factor beta1; Vasoconstrictor Agents | 2007 |
Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology.
Topics: Angiotensin II; Connective Tissue Growth Factor; Diabetic Nephropathies; Extracellular Matrix; Glomerular Mesangium; Glucose Transporter Type 1; Glycosylation; Hexosamines; Humans; Hyperglycemia; Immediate-Early Proteins; Insulin-Like Growth Factor I; Intercellular Signaling Peptides and Proteins; Nitric Oxide; Podocytes; Signal Transduction; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A | 2005 |
Angiotensin II-induced signaling pathways in diabetes.
Topics: Angiotensin II; Cell Division; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Glomerular Mesangium; Glycation End Products, Advanced; Humans; Hyperglycemia; Muscle, Smooth, Vascular; Reactive Oxygen Species; Signal Transduction | 2005 |
A functional role for the tubuloglomerular feedback mechanism.
Topics: Acute Kidney Injury; Angiotensin II; Animals; Benzolamide; Diuretics; Feedback; Glomerular Filtration Rate; Homeostasis; Humans; Hydrostatic Pressure; Hyperglycemia; Kidney Glomerulus; Kidney Tubules; Nephrons; Rats; Renin-Angiotensin System; Sympathetic Nervous System; Ultrafiltration | 1984 |
Diabetic eye disease: how can it be prevented?
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetic Retinopathy; Humans; Hyperglycemia; Laser Therapy; Risk Factors | 2000 |
High glucose-induced activation of protein kinase signaling pathways in vascular smooth muscle cells: a potential role in the pathogenesis of vascular dysfunction in diabetes (review).
Topics: Angiotensin II; Animals; Diabetes Mellitus; Diabetic Angiopathies; Enzyme Activation; Hyperglycemia; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; NF-kappa B; Protein Kinase C | 2002 |
3 trial(s) available for angiotensin ii and Hyperglycemia
Article | Year |
---|---|
Systemic hemodynamic function in humans with type 1 diabetes treated with protein kinase Cβ inhibition and renin-angiotensin system blockade: a pilot study.
Topics: Adult; Angiotensin II; Antihypertensive Agents; Blood Glucose; Diabetes Mellitus, Type 1; Enzyme Inhibitors; Female; Glucose Clamp Technique; Hemodynamics; Humans; Hyperglycemia; Indoles; Infusions, Intravenous; Male; Maleimides; Pilot Projects; Protein Kinase C; Protein Kinase C beta; Renin-Angiotensin System | 2012 |
Neuroendocrine stress hormones do not recreate the postoperative hypercoagulable state.
Topics: Adult; Angiotensin II; Blood Coagulation; Epinephrine; Female; Glucagon; Hemodynamics; Humans; Hydrocortisone; Hyperglycemia; Leukocyte Count; Male; Norepinephrine; Plasminogen Activator Inhibitor 1; Platelet Count; Postoperative Period; Protein C; Stress, Physiological; Time Factors; Tissue Plasminogen Activator; Vasopressins | 1998 |
Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus.
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 1; Female; Glomerular Filtration Rate; Humans; Hyperglycemia; Kidney; Losartan; Male; Natriuresis; Renal Circulation; Renin-Angiotensin System; Vascular Resistance | 1999 |
73 other study(ies) available for angiotensin ii and Hyperglycemia
Article | Year |
---|---|
AT2 Receptor Stimulation Inhibits Vascular Smooth Muscle Cell Senescence Induced by Angiotensin II and Hyperglycemia.
Topics: Angiotensin II; Animals; Carrier Proteins; Cells, Cultured; Cellular Senescence; Glucose; Hyperglycemia; Imidazoles; Male; Mice; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Receptor, Angiotensin, Type 2; Sirolimus; Sulfonamides; Superoxides; Thiophenes | 2022 |
Renal and Vascular Effects of Uric Acid Lowering in Normouricemic Patients With Uncomplicated Type 1 Diabetes.
Topics: Adult; Angiotensin II; Blood Pressure; Case-Control Studies; Diabetes Mellitus, Type 1; Febuxostat; Female; Glomerular Filtration Rate; Gout Suppressants; Humans; Hyperglycemia; Interleukin-18; Linear Models; Male; Nitric Oxide; Nitroglycerin; Renal Plasma Flow, Effective; Renin-Angiotensin System; Uric Acid; Vascular Stiffness; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Young Adult | 2017 |
Losartan reverses COX-2-dependent vascular dysfunction in offspring of hyperglycaemic rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cyclooxygenase 2; Endothelium, Vascular; Female; Hyperglycemia; Losartan; Male; Mesenteric Arteries; Pregnancy; Rats; Rats, Wistar; Vasoconstriction; Vasodilation | 2017 |
MicroRNA-145 regulates disabled-2 and Wnt3a expression in cardiomyocytes under hyperglycaemia.
Topics: Adaptor Proteins, Vesicular Transport; Angiotensin II; Animals; Apoptosis; beta Catenin; Blood Glucose; Diabetes Mellitus, Experimental; Heart Ventricles; Hyperglycemia; Male; MicroRNAs; Myocardium; Myocytes, Cardiac; Rats, Wistar; Wnt3 Protein | 2018 |
Mesangial cells are responsible for orchestrating the renal podocytes injury in the context of malignant hypertension.
Topics: Angiotensin II; Animals; Apoptosis; Cell Proliferation; Cells, Cultured; Culture Media, Conditioned; Glucose; Hydrostatic Pressure; Hyperglycemia; Hypertension, Malignant; Mesangial Cells; Paracrine Communication; Podocytes; Rats | 2013 |
Pancreatic angiotensin-converting enzyme 2 improves glycemia in angiotensin II-infused mice.
Topics: Adaptor Proteins, Signal Transducing; Adenoviridae; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Genetic Therapy; Humans; Hyperglycemia; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Vasoconstrictor Agents | 2013 |
An increased circulating angiotensin II concentration is associated with hypoadiponectinemia and postprandial hyperglycemia in men with nonalcoholic fatty liver disease.
Topics: Adiponectin; Adult; Angiotensin II; Biomarkers; Blood Circulation; Fatty Liver; Humans; Hyperglycemia; Male; Metabolism, Inborn Errors; Middle Aged; Non-alcoholic Fatty Liver Disease | 2013 |
An ethanolic extract of Lindera obtusiloba stems, YJP-14, improves endothelial dysfunction, metabolic parameters and physical performance in diabetic db/db mice.
Topics: Albuminuria; Angiotensin II; Animals; Aorta; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Disease Models, Animal; Endothelium, Vascular; Ethanol; Exercise Tolerance; Gene Expression; Humans; Hyperglycemia; Hypoglycemic Agents; Lindera; Male; Mice; Mice, Transgenic; NADPH Oxidases; Nitric Oxide Synthase Type III; Pioglitazone; Plant Extracts; Prostaglandin-Endoperoxide Synthases; Receptor, Angiotensin, Type 1; Thiazolidinediones | 2013 |
Renal hyperfiltration and systemic blood pressure in patients with uncomplicated type 1 diabetes mellitus.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Blood Pressure; Case-Control Studies; Diabetes Mellitus, Type 1; Female; Glomerular Filtration Rate; Glucose Clamp Technique; Heart Rate; Humans; Hyperglycemia; Kidney; Male; Renin | 2013 |
Exposure of cardiomyocytes to angiotensin II induces over-activation of monoamine oxidase type A: implications in heart failure.
Topics: Aldehyde Dehydrogenase; Angiotensin II; Animals; Biphenyl Compounds; Catalase; Enzyme Activation; Heart Failure; Hyperglycemia; Irbesartan; Losartan; Monoamine Oxidase; Myocytes, Cardiac; Rats; Tetrazoles | 2013 |
Inhibition of MAPK-mediated ACE expression by compound C66 prevents STZ-induced diabetic nephropathy.
Topics: Angiotensin II; Animals; Benzylidene Compounds; Cyclohexanones; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulation; Hyperglycemia; Kidney; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Peptidyl-Dipeptidase A; Protein Kinase Inhibitors; Renin-Angiotensin System; Signal Transduction; Streptozocin | 2014 |
Comparative study of the effects of free bound and carrier protein angiotensin II in experimental hypoglycemia and hyperglycemia.
Topics: Angiotensin II; Animals; Blood Pressure; Drinking Behavior; Heart Rate; Hyperglycemia; Hypoglycemia; Male; Rats, Wistar; S100 Calcium Binding Protein beta Subunit; Serum Albumin, Bovine; Thirst | 2014 |
Esculetin attenuates alterations in Ang II and acetylcholine mediated vascular reactivity associated with hyperinsulinemia and hyperglycemia.
Topics: Acetylcholine; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Antioxidants; Aorta; Blood Pressure; Diabetes Mellitus, Experimental; Hyperglycemia; Hyperinsulinism; Hypertension; Male; Peptidyl-Dipeptidase A; Rats, Wistar; Transforming Growth Factor beta; Umbelliferones | 2015 |
Losartan and ozagrel reverse retinal arteriolar constriction in non-obese diabetic mice.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arterioles; Blood Flow Velocity; Constriction, Pathologic; Female; Fibrinolytic Agents; Hyperglycemia; Losartan; Methacrylates; Mice; Mice, Inbred NOD; Retinal Vessels; Thromboxanes; Venules | 2008 |
Acute hyperglycemia and hyperinsulinemia enhance adrenergic vasoconstriction and decrease calcitonin gene-related peptide-containing nerve-mediated vasodilation in pithed rats.
Topics: Acetylcholine; Acute Disease; Adrenergic Fibers; Angiotensin II; Animals; Calcitonin Gene-Related Peptide; Glucose; Hyperglycemia; Hyperinsulinism; Male; Nitroprusside; Norepinephrine; Octreotide; Rats; Rats, Wistar; Spinal Cord Injuries; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2008 |
Hyperglycemia alters renal cell responsiveness to pressure in a model of malignant hypertension.
Topics: Angiotensin II; Animals; Apoptosis; Cell Line; Cell Proliferation; Endothelial Cells; Epithelial Cells; Hydrogen Peroxide; Hydrostatic Pressure; Hyperglycemia; Hypertension, Malignant; Kidney; Mesangial Cells; Rats; Rats, Sprague-Dawley; Tumor Suppressor Protein p53 | 2009 |
Long-term angiotensin II blockade may improve not only hyperglycemia but also age-associated cardiac fibrosis.
Topics: Aging; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fibrosis; Heart Failure; Hyperglycemia; Male; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Tetrazoles | 2009 |
High ambient glucose augments angiotensin II-induced proinflammatory gene mRNA expression in human mesangial cells: effects of valsartan and simvastatin.
Topics: Angiotensin II; Gene Expression Regulation; Glucose; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Inflammation; Kidney; Mesangial Cells; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Simvastatin; Tetrazoles; Valine; Valsartan | 2009 |
Vascular-protective effects of high-density lipoprotein include the downregulation of the angiotensin II type 1 receptor.
Topics: Angiotensin II; Animals; Aorta; Apolipoprotein A-I; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dimerization; Down-Regulation; Endothelium, Vascular; Gene Transfer Techniques; Humans; Hyperglycemia; Lipoproteins, HDL; Male; NADPH Oxidase 4; NADPH Oxidases; Nitric Oxide Synthase Type III; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Signal Transduction | 2009 |
Human glomerular endothelium: interplay among glucose, free fatty acids, angiotensin II, and oxidative stress.
Topics: Angiotensin II; Cells, Cultured; Cyclooxygenase 2; Dose-Response Relationship, Drug; Endothelium; Epoprostenol; Fatty Acids, Nonesterified; Glucose; Humans; Hyperglycemia; Kidney Glomerulus; NADPH Oxidases; Nitric Oxide Synthase Type III; Oxidative Stress; Oxygen; Reactive Oxygen Species; Superoxides | 2010 |
Fibronectin synthesis by high glucose level mediated proliferation of mouse embryonic stem cells: Involvement of ANG II and TGF-beta1.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Calcium Signaling; Cell Count; Cell Proliferation; DNA Replication; Embryonic Stem Cells; Fibronectins; Glucose; Hyperglycemia; JNK Mitogen-Activated Protein Kinases; Losartan; Mice; Phosphorylation; Protein Kinase C; Receptor, Angiotensin, Type 1; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta1 | 2010 |
Age is a determinant of acute hemodynamic responses to hyperglycemia and angiotensin II in humans with uncomplicated type 1 diabetes mellitus.
Topics: Adolescent; Adult; Aging; Angiotensin II; Blood Pressure; Diabetes Mellitus, Type 1; Female; Glomerular Filtration Rate; Glucose Clamp Technique; Hemodynamics; Humans; Hyperglycemia; Kidney; Male; Polyuria; Renal Plasma Flow, Effective; Renin-Angiotensin System; Thirst; Vascular Resistance | 2010 |
Angiotensin AT1 receptor activation mediates high glucose-induced epithelial-mesenchymal transition in renal proximal tubular cells.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Cadherins; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Matrix; Fibronectins; Glucose; Hyperglycemia; Kidney; Kidney Tubules, Proximal; Losartan; Peptidyl-Dipeptidase A; Rats; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger; Transforming Growth Factor beta1 | 2010 |
Acute hyperglycemia rapidly stimulates VEGF mRNA translation in the kidney. Role of angiotensin type 2 receptor (AT2).
Topics: Angiotensin II; Animals; Female; Gene Expression Regulation; Heterogeneous-Nuclear Ribonucleoprotein K; Hyperglycemia; Imidazoles; Kidney; Kidney Cortex; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Pyridines; Receptor, Angiotensin, Type 2; RNA, Messenger; Signal Transduction; Time Factors; Vascular Endothelial Growth Factor A | 2010 |
The contribution of α1B-adrenoceptor subtype in the renal vasculature of fructose-fed Sprague-Dawley rats.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Angiotensin II; Animals; Dietary Carbohydrates; Dose-Response Relationship, Drug; Fructose; Hemodynamics; Hyperglycemia; Hyperinsulinism; Hypertension; Kidney; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Adrenergic, alpha-1; Regional Blood Flow; Vasoconstriction; Vasoconstrictor Agents | 2011 |
Retinoic acid receptor-mediated signaling protects cardiomyocytes from hyperglycemia induced apoptosis: role of the renin-angiotensin system.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Apoptosis; Blood Glucose; Cells, Cultured; Diabetes Mellitus; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Hyperglycemia; Hypoglycemic Agents; Male; Myocytes, Cardiac; Oxidative Stress; Rats; Rats, Sprague-Dawley; Rats, Zucker; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptors, Retinoic Acid; Renin-Angiotensin System; Retinoic Acid Receptor alpha; Retinoid X Receptor alpha; RNA Interference; RNA, Messenger; Signal Transduction; Time Factors; Tretinoin | 2011 |
High-fructose feeding impacts on the adrenergic control of renal haemodynamics in the rat.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Antagonists; Angiotensin II; Animals; Dietary Carbohydrates; Fructose; Hemodynamics; Hyperglycemia; Hyperinsulinism; Hypertension; Hypertriglyceridemia; Kidney; Male; Norepinephrine; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, Angiotensin; Renal Circulation; Vasoconstrictor Agents | 2012 |
Des-aspartate-angiotensin-I and angiotensin IV improve glucose tolerance and insulin signalling in diet-induced hyperglycaemic mice.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Glucose; Cystinyl Aminopeptidase; Dietary Fats; Dietary Sucrose; Drug Administration Schedule; Glucose Intolerance; Hyperglycemia; Indomethacin; Insulin; Insulin Receptor Substrate Proteins; Janus Kinase 2; Losartan; Male; Mice; Mice, Inbred C57BL; Phosphatidylinositol 3-Kinases; Receptor, Angiotensin, Type 1; Signal Transduction | 2011 |
Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway.
Topics: Angiotensin I; Angiotensin II; Animals; Body Weight; Diabetes Mellitus; ErbB Receptors; Glucose; Hyperglycemia; Male; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Quinazolines; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; src-Family Kinases; Transcriptional Activation; Tyrphostins | 2012 |
Hyperglycaemia emerging during general anaesthesia induces rat acute kidney injury via impaired microcirculation, augmented apoptosis and inhibited cell proliferation.
Topics: Acute Kidney Injury; Anesthesia, General; Angiotensin II; Animals; Apoptosis; Biomarkers; Blood Glucose; Blood Pressure; Cell Proliferation; Cystatin C; Disease Models, Animal; Glucose; Hyperglycemia; Insulin; Kidney; Microcirculation; Rats; Rats, Sprague-Dawley; Renal Circulation; Time Factors; Urea | 2012 |
Angiotensin II type 2 receptor is critical for the development of human fetal pancreatic progenitor cells into islet-like cell clusters and their potential for transplantation.
Topics: Angiotensin II; Animals; Cell Differentiation; Cells, Cultured; Diabetes Mellitus, Experimental; Fetus; Gene Expression; Gene Expression Profiling; Gene Expression Regulation, Developmental; Gene Knockdown Techniques; Humans; Hyperglycemia; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice; Mice, Nude; Mitosis; ras Proteins; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Stem Cells | 2012 |
Diabetes-associated angiotensin activation enhances liver metastasis of colon cancer.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chymases; Colonic Neoplasms; Diabetes Complications; Diabetes Mellitus; Glucose; Glycated Hemoglobin; HT29 Cells; Humans; Hyperglycemia; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Oligoribonucleotides, Antisense; Receptor, Angiotensin, Type 1; Renin; RNA Interference; RNA, Small Interfering | 2012 |
Characterization of Angiotensin-(1-7) effects on the cardiovascular system in an experimental model of type-1 diabetes.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Captopril; Cardiovascular System; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Endothelin-1; Hyperglycemia; Kidney; Losartan; Male; NADPH Oxidases; Peptide Fragments; Peptides; Peptidyl-Dipeptidase A; Prostaglandins; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Reperfusion Injury | 2012 |
Angiotensin II impairs glucose utilization in obese Zucker rats by increasing HPA activity via an adrenal-dependent mechanism.
Topics: Adrenalectomy; Adrenocorticotropic Hormone; Angiotensin II; Animals; Blood Glucose; Corticosterone; Disease Models, Animal; Glucose Intolerance; Glucose Tolerance Test; Hyperglycemia; Hypothalamo-Hypophyseal System; Insulin; Insulin Secretion; Male; Metabolic Syndrome; Obesity; Pituitary-Adrenal System; Random Allocation; Rats; Rats, Zucker; Up-Regulation | 2013 |
Modification of normal activities of angiotensin II and angiotensin IV in rats with experimental hypo- and hyperglycemia.
Topics: Angiotensin II; Animals; Blood Glucose; Carbohydrate Metabolism; Hemodynamics; Homeostasis; Hyperglycemia; Hypoglycemia; Injections, Intraperitoneal; Male; Rats; Rats, Wistar; Renin-Angiotensin System | 2012 |
Hypoxia and high glucose upregulate AT1 receptor expression and potentiate ANG II-induced proliferation in VSM cells.
Topics: Angiotensin II; Animals; Blotting, Northern; Cell Division; Cell Hypoxia; Cells, Cultured; Glucose; Hyperglycemia; Male; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; RNA, Messenger; Up-Regulation | 2003 |
Lisofylline, a novel antiinflammatory compound, protects mesangial cells from hyperglycemia- and angiotensin II-mediated extracellular matrix deposition.
Topics: Angiotensin II; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Connective Tissue Growth Factor; Cyclic AMP Response Element-Binding Protein; Extracellular Matrix; Extracellular Matrix Proteins; Fibronectins; Gene Expression; Glomerular Mesangium; Glucose; Humans; Hyperglycemia; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pentoxifylline; Phosphorylation; Transforming Growth Factor beta; Vasoconstrictor Agents | 2003 |
Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetic Nephropathies; DNA-Binding Proteins; Enzyme Inhibitors; Hyperglycemia; Intracellular Signaling Peptides and Proteins; Janus Kinase 2; Kidney Glomerulus; Male; Milk Proteins; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; STAT5 Transcription Factor; Tetrazoles; Trans-Activators; Transcription, Genetic; Tyrphostins | 2004 |
Tempol augments angiotensin II-induced AT2 receptor-mediated relaxation in diabetic rat thoracic aorta.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Antioxidants; Aorta, Thoracic; Blood Pressure; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Drug Synergism; Enzyme Inhibitors; Hyperglycemia; Male; NG-Nitroarginine Methyl Ester; Potassium Channels; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Spin Labels; Superoxide Dismutase; Tritium; Vasoconstrictor Agents; Vasodilation | 2004 |
Reversal of hyperglycemic preconditioning by angiotensin II: role of calcium transport.
Topics: Angiotensin II; Animals; Apoptosis; Calcium; Calcium Channels, T-Type; Cardiotonic Agents; Cells, Cultured; Glucose; Hyperglycemia; Myocytes, Cardiac; Rats; Signal Transduction; Vasoconstrictor Agents | 2005 |
Modulation of potassium currents by angiotensin and oxidative stress in cardiac cells from the diabetic rat.
Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Cells, Cultured; Diabetes Mellitus, Experimental; Female; Heart Ventricles; Hyperglycemia; Male; Membrane Potentials; Myocytes, Cardiac; Oxidative Stress; Potassium; Potassium Channels; Rats; Rats, Sprague-Dawley; Sex Characteristics; Superoxides | 2005 |
Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Captopril; Diabetes Mellitus, Experimental; Hydrogen Peroxide; Hyperglycemia; Mice; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Signal Transduction; Superoxides; Tetrazoles; Vasodilation | 2007 |
Induction of monocyte chemoattractant protein-1 expression by angiotensin II in the pancreatic islets and beta-cells.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Line, Tumor; Chemokine CCL2; Diabetes Mellitus, Type 1; Gene Expression; Hyperglycemia; Imidazoles; Insulin-Secreting Cells; Insulinoma; Interleukin-1beta; Losartan; Mice; Mice, Inbred NOD; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Pancreatic Neoplasms; Promoter Regions, Genetic; Protein-Tyrosine Kinases; Pyridines; Rats; Receptor, Angiotensin, Type 1; RNA, Messenger; Vasoconstrictor Agents | 2007 |
PPAR gamma agonists partially restores hyperglycemia induced aggravation of vascular dysfunction to angiotensin II in thoracic aorta isolated from rats with insulin resistance.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Blood Pressure; Dietary Fats; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Male; Pioglitazone; PPAR gamma; Prediabetic State; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Rosiglitazone; Streptozocin; Thiazolidinediones; Vasoconstriction; Vasoconstrictor Agents | 2007 |
Captopril inhibits capillary degeneration in the early stages of diabetic retinopathy.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Body Weight; Capillaries; Captopril; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Cells; Hyperglycemia; Leukostasis; Losartan; Male; Rats; Rats, Inbred Lew; Retina; Retinal Vessels; Vascular Cell Adhesion Molecule-1 | 2007 |
Proapoptotic and antiapoptotic effects of hyperglycemia: role of insulin signaling.
Topics: Angiotensin II; Animals; Animals, Newborn; Apoptosis; bcl-2-Associated X Protein; Cells, Cultured; Glucose; Hyperglycemia; Insulin; Insulin Resistance; Myocytes, Cardiac; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Signal Transduction | 2008 |
Effects of hyperglycemia on angiotensin II receptor type 1 expression and insulin secretion in an INS-1E pancreatic beta-cell line.
Topics: Angiotensin II; Animals; Cell Line; Dose-Response Relationship, Drug; Glucose; Hyperglycemia; Insulin; Insulin Secretion; Insulin-Secreting Cells; Oxidative Stress; Rats; Receptor, Angiotensin, Type 1; RNA, Messenger; Tissue Distribution | 2008 |
Hyperglycemic action of angiotensin II in freely moving rats.
Topics: Analysis of Variance; Angiotensin II; Animals; Dose-Response Relationship, Drug; Hemorrhage; Hyperglycemia; Injections, Intravenous; Male; Movement; Rats; Rats, Wistar | 1995 |
The cardiac renin-angiotensin system in STZ-induced diabetes.
Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Diabetes Mellitus, Experimental; Gene Expression; Hyperglycemia; Imidazoles; Insulin; Kinetics; Losartan; Male; Myocardium; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Reference Values; Renin-Angiotensin System; RNA, Messenger; Tetrazoles | 1994 |
Hyperglycemia alters cytoplasmic Ca2+ responses to capacitative Ca2+ influx in rat aortic smooth muscle cells.
Topics: Adenosine Triphosphate; Angiotensin II; Animals; Aorta; Calcium; Calcium Channel Blockers; Calcium-Transporting ATPases; Cells, Cultured; Cytoplasm; Hyperglycemia; Imidazoles; Male; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum; Terpenes; Thapsigargin | 1995 |
Effect of [1-Sar,8-Thr]-angiotensin II on the hyperglycemic response to hemorrhage in adrenodemedullated and guanethidine-treated rats.
Topics: Adrenal Medulla; Adrenergic Antagonists; Angiotensin II; Animals; Blood Glucose; Guanethidine; Hemorrhage; Hyperglycemia; Male; Rats; Rats, Wistar; Sympatholytics | 1995 |
Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Adult; Angiotensin II; Animals; Aorta; Arachidonate 12-Lipoxygenase; Cell Line, Transformed; Cells, Cultured; Endothelial Growth Factors; Gene Expression Regulation; Glucose; Humans; Hyperglycemia; Kinetics; Lymphokines; Muscle, Smooth, Vascular; RNA, Messenger; Swine; Transcription, Genetic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1997 |
A central role for protein kinase C overactivity in diabetic glomerulosclerosis: implications for prevention with antioxidants, fish oil, and ACE inhibitors.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Diabetic Angiopathies; Diabetic Nephropathies; Enzyme Activation; Fish Oils; Heparitin Sulfate; Humans; Hyperglycemia; Kidney Glomerulus; Lipid Peroxidation; Models, Biological; Nitric Oxide; Protein Kinase C; Thromboxane A2; Transforming Growth Factor beta | 1998 |
The reduction in alcohol intake in rats by isoproterenol is attenuated by indomethacin but not enalapril: relationship to blood glucose levels.
Topics: Adrenergic beta-Agonists; Alcohol Drinking; Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Drinking; Enalapril; Ethanol; Hyperglycemia; Indomethacin; Isoproterenol; Male; Rats; Rats, Wistar | 1998 |
The hyperglycemia induced by angiotensin II in rats is mediated by AT1 receptors.
Topics: Angiotensin I; Angiotensin II; Angiotensins; Animals; Antihypertensive Agents; Hyperglycemia; Losartan; Male; Rats; Rats, Wistar; Receptors, Angiotensin; Vasoconstrictor Agents | 1998 |
Hyperglycaemia abolishes the antihypertrophic efficacy of bradykinin in rat ventricular myocytes.
Topics: Angiotensin II; Animals; Aorta; Bradykinin; Cardiomegaly; Cattle; Coculture Techniques; Endothelium, Vascular; Glucose; Heart Ventricles; Hyperglycemia; Male; Myocardium; Phenylalanine; Rats; Rats, Sprague-Dawley | 1999 |
Gluconeogenesis activation after intravenous angiotensin II in freely moving rats.
Topics: Angiotensin II; Animals; Blood Glucose; Carbon Radioisotopes; Gluconeogenesis; Hyperglycemia; Infusions, Intravenous; Kinetics; Liver; Rats | 1999 |
Hyperglycemia enhances angiotensin II-induced janus-activated kinase/STAT signaling in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Cell Division; Cells, Cultured; Glucose; Hyperglycemia; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction; Tyrosine | 1999 |
Effect of angiotensin II antagonist eprosartan on hyperglycemia-induced activation of intrarenal renin-angiotensin system in healthy humans.
Topics: Acrylates; Adult; Angiotensin II; Diabetic Nephropathies; Glomerular Filtration Rate; Hemodynamics; Humans; Hyperglycemia; Imidazoles; Kidney; Male; Middle Aged; Renal Circulation; Renin; Renin-Angiotensin System; Thiophenes | 2000 |
Local blood flow regulation in transplanted rat pancreatic islets: influence of adenosine, angiotensin II, and nitric oxide inhibition.
Topics: Adenosine; Angiotensin II; Animals; Blood Glucose; Blood Pressure; Body Weight; Enzyme Inhibitors; Hematocrit; Hyperglycemia; Infusions, Intravenous; Injections; Insulin; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Nitric Oxide Synthase; Nitroarginine; Rats; Rats, Inbred WF; Regional Blood Flow | 2000 |
Hyperinsulinemia enhances transcriptional activity of nuclear factor-kappaB induced by angiotensin II, hyperglycemia, and advanced glycosylation end products in vascular smooth muscle cells.
Topics: Alkyl and Aryl Transferases; Angiotensin II; Animals; Cattle; Cells, Cultured; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Enzyme Inhibitors; Genes, Reporter; Glycation End Products, Advanced; Hyperglycemia; Hyperinsulinism; Insulin; Luciferases; Muscle, Smooth, Vascular; NF-kappa B; Phosphorylation; Time Factors; Transcription, Genetic; Transfection | 2000 |
Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death.
Topics: Angiotensin II; Animals; Apoptosis; Cells, Cultured; DNA; Gene Expression Regulation; Glycosylation; Heart Ventricles; Hydrogen-Ion Concentration; Hyperglycemia; JNK Mitogen-Activated Protein Kinases; Losartan; Male; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Myocardium; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Rats, Sprague-Dawley; Tumor Suppressor Protein p53 | 2001 |
Hyperglycemia enhances VSMC proliferation with NF-kappaB activation by angiotensin II and E2F-1 augmentation by growth factors.
Topics: Angiotensin II; Animals; CDC2 Protein Kinase; Cell Cycle Proteins; Cell Division; Cells, Cultured; DNA; DNA-Binding Proteins; E2F Transcription Factors; E2F1 Transcription Factor; Fetal Blood; Gene Expression Regulation; Glucose; Growth Substances; Hyperglycemia; Hyperplasia; Male; Muscle, Smooth, Vascular; NF-kappa B; Promoter Regions, Genetic; Protein Binding; Rats; Rats, Sprague-Dawley; Transcription Factor RelA; Transcription Factors; Transcription, Genetic | 2002 |
Angiotensin II induces human TGF-beta 1 promoter activation: similarity to hyperglycaemia.
Topics: Angiotensin II; Animals; Base Sequence; beta-Galactosidase; Binding Sites; Cell Line; Gene Expression Regulation; Genes, Reporter; Glomerular Mesangium; Glucose; Humans; Hyperglycemia; Mitogen-Activated Protein Kinases; Mutagenesis, Site-Directed; Oligodeoxyribonucleotides; p38 Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Recombinant Proteins; Swine; Transcription Factors; Transcriptional Activation; Transfection; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2002 |
Plasma renin activity and blood volume in uncontrolled diabetes. Ketoacidosis, a state of secondary aldosteronism.
Topics: Adult; Aldosterone; Angiotensin II; Blood Glucose; Blood Volume; Diabetic Ketoacidosis; Female; Humans; Hyperaldosteronism; Hyperglycemia; Insulin; Ketosis; Male; Renin | 1975 |
[Effect of increased plasma levels of glucose, adrenaline, and angiotensin upon glucose metabolism of totally ischemic and normally perfused rat brain].
Topics: Angiotensin II; Animals; Blood Glucose; Brain; Epinephrine; Glucose; Hyperglycemia; Ischemia; Perfusion; Rats | 1975 |
Mechanisms in rabbit aorta for hyperglycaemia-induced alterations in angiotensin II and norepinephrine effects.
Topics: Angiotensin II; Animals; Aorta; Glucose; Hyperglycemia; Inositol; Kinetics; Male; Muscle, Smooth, Vascular; Norepinephrine; Potassium; Rabbits; Rubidium; Sodium-Potassium-Exchanging ATPase | 1992 |
Morphology and functional responses of isolated zona glomerulosa cells of streptozotocin-induced diabetic rats.
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Corticosterone; Diabetes Mellitus, Experimental; Hyperglycemia; Male; Microscopy, Electron; Potassium; Rats; Rats, Inbred Strains; Streptozocin; Zona Glomerulosa | 1990 |
Corticotropin-releasing factor: effects on the autonomic nervous system and visceral systems.
Topics: Adrenal Medulla; Adrenocorticotropic Hormone; Angiotensin II; Animals; Autonomic Nervous System; Blood Pressure; Cardiovascular System; Corticosterone; Corticotropin-Releasing Hormone; Dogs; Epinephrine; Heart Rate; Hyperglycemia; Norepinephrine; Rats; Sympathetic Nervous System | 1985 |
Polyol pathway in aorta: regulation by hormones.
Topics: Alcohol Oxidoreductases; Angiotensin II; Animals; Aorta, Thoracic; Cyclic AMP; Epinephrine; Humans; Hyperglycemia; Isoproterenol; Norepinephrine; Ouabain; Rabbits; Sorbitol | 1969 |
Studies on angiotensin-induced glycosuria.
Topics: Angiotensin II; Animals; Blood Pressure; Glycosuria; Hyperglycemia; Injections, Intramuscular; Injections, Intraperitoneal; Injections, Intravenous; Rabbits; Renin; Time Factors | 1969 |
Effect of aldosterone on angiotensin-induced glycosuria.
Topics: Aldosterone; Angiotensin II; Animals; Glycosuria; Hyperglycemia; Injections, Intravenous; Rabbits; Renin; Spironolactone; Time Factors; Urine | 1969 |
Mechanism of angiotensin-induce glycosuria.
Topics: Aldosterone; Angiotensin II; Animals; Blood Glucose; Epinephrine; Glycosuria; Hyperglycemia; Injections, Intravenous; Mouth; Rabbits; Spironolactone; Time Factors; Urine | 1969 |